Ipca Laboratories Limited
IPCALAB
Rangering i aksjer
#3415
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aksjekurs
$20.02
Sist synkronisert: 2026-10-19
Markedsverdi
$5.08B
Endring (1 dag)
-1.65%
Endring (1 år)
38.46%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategori
Healthcare
Utbytteavkastning for Ipca Laboratories Limited (IPCALAB)
Ipca Laboratories Limited (aksjesymbol: IPCALAB) sin utbytteavkastning (TTM) per 2024-03-31 er: 0.16%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.35%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.35%
Utbytteavkastning for Ipca Laboratories Limited (IPCALAB) fra 2005 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.31% | 6.90% |
| 2025 | 0.29% | 81.25% |
| 2024 | 0.16% | -67.35% |
| 2023 | 0.49% | 28.95% |
| 2022 | 0.38% | -9.52% |
| 2021 | 0.42% | -39.13% |
| 2020 | 0.69% | 430.77% |
| 2019 | 0.13% | -27.78% |
| 2018 | 0.18% | 0.00% |
| 2017 | 0.00% | -100.00% |
| 2016 | 0.21% | -54.35% |
| 2015 | 0.46% | -25.81% |
| 2014 | 0.62% | -11.43% |
| 2013 | 0.70% | -36.36% |
| 2012 | 1.10% | -5.17% |
| 2011 | 1.16% | 2.65% |
| 2010 | 1.13% | -72.10% |
| 2009 | 4.05% | 185.21% |
| 2008 | 1.42% | 15.45% |
| 2007 | 1.23% | -31.28% |
| 2006 | 1.79% | -13.11% |
| 2005 | 2.06% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
